Nevertheless, further analyses of caspase-2 in AML cohorts are called for, especially in the light of NPM1 being part of a nucleolar route to caspase-2 activation [24, 51] and the NPM1c + mutation found in AML. The gene discussed is CASP2; the disease is acute myeloid leukemia.